H.U. Group Holdings Inc (MRCHF) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of H.U. Group Holdings Inc $13.28, price $23.35, upside -43.1%, quality 66 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Fair value above price? No
- Good quality? Yes
- Add to watchlist
H.U. Group Holdings Inc
MRCHF · USStretched ValuationStrong overvaluation with only moderate quality.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Sep 23, 2026.
How to read this chart
60‑month range $13.09 – $30.32 · fair‑value band $9.96 – $16.60 · the $23.35 price screens above the $13.28 fair value. As of Sep 23, 2026.
Every Wednesday you see whether H.U. Group Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
H.U. Group Holdings, Inc., together with its subsidiaries, operates healthcare business in Japan, the United States, Europe, and internationally.
Show more
H.U. Group Holdings, Inc., together with its subsidiaries, operates healthcare business in Japan, the United States, Europe, and internationally. The Lab Testing and Its Related Services segment provides general testing services to medical institutions that include esoteric testing, such as genetic and oncology testing; companion diagnostics-related tests for cancer treatment; omics analysis comprising whole genome sequencing and proteome analysis; comprehensive support for clinical trials and research, including pre-trial setup work, specimen collection and transport, measuring, result reports, and data management, as well as SaaS for general practitioners and personal health records. Its In-Vitro Diagnostics segment provides Lumipulse system products, an automated chemiluminescence enzyme immunoassay system that offers reagents; testing services for neurodegenerative diseases; and rapid diagnostics kit for infectious diseases comprising influenza and COVID-19, as well as cerebrospinal fluid reagent. This segment also develops blood-based reagents and biomarkers specifically for neurodegenerative diseases, such as Alzheimer's. The Healthcare-related Services segment offers in-house sterilization for central supply rooms in hospitals and external sterilization at sterilization centers; operating room support, endoscopy room support, medical equipment maintenance and inspection, and logistics management and transportation services; support for important tasks related to hospital administration work, including the sale of medical equipment, supplies, and consumables related to central supply rooms and operating rooms; bulk rentals of nursing care equipment, supplying equipment, including wheelchairs and nursing beds; and home medical care and nursing services. The company was formerly known as Miraca Holdings Inc. and changed its name to H.U. Group Holdings, Inc. in July 2020. H.U. Group Holdings, Inc. was incorporated in 1950 and is headquartered in Tokyo, Japan.
Stock analysis
H.U. Group Holdings Inc (MRCHF) currently trades at $23.35, while our model-based Fair Value estimate is $13.28, implying the stock looks roughly 75.8% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $22.42 per share, and 6 of the 22 models we run sit above the $23.35 price.
Bear case: the Earnings-Based group reads lowest at $4.50, and 16 of the 22 models stay below the price. Evidence for this calculation is high.
Scenario range: $9.96 (bear) to $16.60 (bull), the price of $23.35 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 66/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
H.U. Group Holdings Inc reported revenue of ¥249B in FY2026 versus ¥273B in FY2022, a compound −2.3%/yr. Reported net income was ¥6.9B in FY2026, compounding −30.6%/yr from FY2022.
Key figures
Market cap $1.3B · P/E ratio 30.7 · P/S ratio 0.85 · EPS (TTM) $0.7600 · Net margin 2.8% · Return on equity 4.9% · Return on assets (EBIT) 5.4% · Operating margin 1.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 11% below its 52-week high and 26% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −5% fair-value upside, at −43%, MRCHF screens richer than that median.
Fair Value models
All 22 models by family
Notify me when MRCHF reaches fair value
Put MRCHF on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Quality Score breakdown
Of which business quality 66 · Market factors (momentum, volatility) 43
Revenue & earnings trend
Growth Forecast
MRCHF screens 76% overvalued. Compare with Thermo Fisher Scientific Inc →
Compare H.U. Group Holdings Inc with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 141 stocks
Valuation Multiplesvs Diagnostics & Research median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Thermo Fisher Scientific Inc TMO | $658.52 | $682.58 | +4% |
| Danaher Corporation DHR | $221.09 | $207.76 | −6% |
| WuXi AppTec Co 2359 | HK$207.60 | HK$228.36 | +10% |
| Lonza Group LONN | CHF 562.80 | CHF 151.69 | −73% |
| IDEXX Laboratories, Inc IDXX | $521.50 | $495.84 | −5% |
| Agilent Technologies, Inc A | $167.26 | $63.90 | −62% |
| Waters Corporation WAT | $425.74 | $106.31 | −75% |
| IQVIA Holdings IQV | $270.09 | $295.80 | +10% |
| Illumina, Inc ILMN | $247.46 | $272.21 | +10% |
| Mettler-Toledo International Inc MTD | $1,491 | $635.75 | −57% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is H.U. Group Holdings Inc (MRCHF) overvalued or undervalued?
What is the fair value of MRCHF?
What is the quality score of MRCHF?
What is the price target for H.U. Group Holdings Inc (MRCHF)?
What is the H.U. Group Holdings Inc stock forecast for 2026?
What is the revenue of H.U. Group Holdings Inc (MRCHF)?
What growth is priced into H.U. Group Holdings Inc (MRCHF)?
What discount rate (WACC) does the fair value of MRCHF use?
What is a reverse DCF?
How much growth has H.U. Group Holdings Inc (MRCHF) delivered so far?
How fast is the sector of H.U. Group Holdings Inc (MRCHF) growing?
What is the free cash flow yield of H.U. Group Holdings Inc (MRCHF)?
What is the intrinsic value of H.U. Group Holdings Inc (MRCHF)?
Is H.U. Group Holdings Inc stock overvalued or undervalued in 2026?
Is fair value the same as the market price of MRCHF?
How much is H.U. Group Holdings Inc worth?
What do the bullish and bearish scenarios say about MRCHF?
What is the P/E ratio of MRCHF?
How solid is the balance sheet of H.U. Group Holdings Inc (MRCHF)?
How far is MRCHF from its 52-week high?
Which stocks are comparable to H.U. Group Holdings Inc?
Is H.U. Group Holdings Inc stock attractive at the current price?
How is the fair value of MRCHF calculated?
Is it still worth investing in stocks now?
What is the share price of H.U. Group Holdings Inc (MRCHF)?
What should I pay attention to with H.U. Group Holdings Inc right now?
Where does the earnings growth of H.U. Group Holdings Inc (MRCHF) come from?
Key figures of H.U. Group Holdings Inc
How large is the market capitalisation of H.U. Group Holdings Inc (MRCHF)?
What is the P/S ratio of H.U. Group Holdings Inc (MRCHF)?
What are the earnings per share of H.U. Group Holdings Inc (MRCHF)?
What is the net margin of H.U. Group Holdings Inc (MRCHF)?
What is the return on equity of H.U. Group Holdings Inc (MRCHF)?
What is the EBIT return on assets of H.U. Group Holdings Inc (MRCHF)?
What is the operating margin of H.U. Group Holdings Inc (MRCHF)?
How fast is revenue growing at H.U. Group Holdings Inc (MRCHF)?
How fast are earnings growing at H.U. Group Holdings Inc (MRCHF)?
How much net debt does H.U. Group Holdings Inc (MRCHF) carry?
Watch H.U. Group Holdings Inc in the live analysis
One click puts H.U. Group Holdings Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.